ARPHA OAI-PMH Endpoint
metadata only
CC BY 4.0
Increased interleukin-6 and hepcidin-25 are associated with restless legs syndrome in rheumatoid arthritis patients
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Vitamin D in the Treatment of Primary Restless Legs Syndrome#903994
- A Proof of Concept, Phase 2, Double-blind, Randomized Trial With d-Methadone Product Versus Placebo#1085430
- JAK-STAT pathway inhibition modulates centrally sensitised default mode network hubs in rheumatoid arthritis pain#448664
- Efficacy and Safety of Selective JAK 1 Inhibitor Filgotinib in Active Rheumatoid Arthritis Patients With Inadequate Response to Methotrexate#1113241
- Phase II Trial of VDJ001 in Patients With Moderate-to-severe Active Rheumatoid Arthritis#891796
Record · ID 286912
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive